Sarah Krug BA, MS

Sarah Krug is the CEO of CANCER101, a patient advocacy organization whose mission is to help patients and caregivers navigate the cancer journey and partner with their healthcare team to make informed decisions. Sarah is also the founder of the Health Collaboratory, a global innovations hub that paves the path for participatory co-design and collaboration in healthcare.In addition, The Health Collaboratory has engaged in participatory co-design with patients and caregivers to launch innovations such as Prescription to Learn.She is the Acting Executive Director of the Society for Participatory Medicine, whose mission is to enable collaborative partnerships across the healthcare continuum.

Sarah serves on the board of the National Organization for Rare Disorders and is Research Chair of the Cancer Education Network. She previously held the position of Global Education Director in the Medical Education Group at Pfizer, as well as patient advocacy relations. She also established the Global Investigator Initiated Research Program at Pfizer.Prior to joining Pfizer, Sarah spearheaded the development of the Pediatric Disease Management clinical pathways and conducted clinical research at Memorial Sloan-Kettering Cancer Center.